Lisa Decker, PhD

September 14, 2020 6:51 pm Published by

Lisa Decker, PhD, joined the board of directors for Chimerix in December 2023.  She currently serves as Chief Business Officer at IGM Biosciences, Inc., and brings more than 25 years of drug development and business development experience.  Prior to her role at IGM Biosciences, Dr. Decker was Chief Business Officer at Atreca Inc., where she oversaw the business development and alliance management functions. Before that, she served in multiple roles at Nektar Therapeutics, most recently serving as Vice President, Business Development. Earlier in her career, Dr. Decker served in several roles at the Office of Technology Management at the University of Massachusetts Medical School. Dr. Decker received her Ph.D. in Immunology from Tufts University School of Medicine and her B.A. in Biology from the College of the Holy Cross.

Categorised in:

This post was written by Michelle LaSpaluto